404
Rapid Diagnostic Kits Market Analysis | 2023-2028
Rapid Diagnostic Kits Market Size, Share, Trends, Dynamics, Forecast, & Growth Analysis: 2023-2028
The healthcare industry recently focused on expediting disease diagnosis through testing. Consequently, rapid diagnostic test kits have been developed to offer instant access to diagnose patients with various types of diseases and decide the kind of required treatment. These rapid diagnostic kits offer quick results and are cost-effective and easily available.
The rapid diagnostic kits market was estimated at USD 14.7 billion in 2022,
The rapid diagnostic kits market is likely to reach USD 18.3 billion in 2028.
The rapid diagnostic kits market is likely to grow at a CAGR of 3.66% during 2023-2028.
Acon Laboratories, Inc. (The U.S), Alfa Scientific Designs Inc. (The U.S), Abbott Laboratories (The U.S), Artron Laboratories Inc. (Canada), Becton, Dickinson And Company (The U.S), BTNX Inc (Canada), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (The U.S), Cardinal Health (The U.S) and Danaher Corporation (The U.S) are among the top players in the market.
North America witnessed the highest share in the market in 2022.
The over-the-counter kits segment garnered the highest market share of more than 50% in 2022 and is likely to register a substantial CAGR during the review period.
Rapid Diagnostic Kits companies, Rapid Diagnostic Kits vendors, R&D companies, Hospitals, Drug manufacturing companies are the target audience in the market.